Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure.

artificial intelligence blood pressure machine learning neural networks, computer risk factors

Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
25 Apr 2024
Historique:
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP). The performance of the novel risk score was compared with existing risk scores, and the possibility of predicting ABP phenotypes utilizing clinical variables was assessed. Using data from 59 124 patients enrolled in the Spanish ABP Monitoring registry, machine-learning approaches (logistic regression, gradient-boosted decision trees, and deep neural networks) and stepwise forward feature selection were used. For the prediction of cardiovascular mortality, deep neural networks yielded the highest clinical performance. The novel mortality prediction models using OBP and ABP outperformed other risk scores. The area under the curve achieved by the novel approach, already when using OBP variables, was significantly higher when compared with the area under the curve of the Framingham risk score, Systemic Coronary Risk Estimation 2, and Atherosclerotic Cardiovascular Disease score. However, the prediction of cardiovascular mortality with ABP instead of OBP data significantly increased the area under the curve (0.870 versus 0.865; The receiver operating characteristic curves for cardiovascular mortality using ABP and OBP with deep neural network models outperformed all other risk metrics, indicating the potential for improving current risk scores by applying state-of-the-art machine learning approaches. The prediction of cardiovascular mortality using ABP data led to a significant increase in area under the curve and performance metrics.

Sections du résumé

BACKGROUND UNASSIGNED
Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).
METHODS UNASSIGNED
The performance of the novel risk score was compared with existing risk scores, and the possibility of predicting ABP phenotypes utilizing clinical variables was assessed. Using data from 59 124 patients enrolled in the Spanish ABP Monitoring registry, machine-learning approaches (logistic regression, gradient-boosted decision trees, and deep neural networks) and stepwise forward feature selection were used.
RESULTS UNASSIGNED
For the prediction of cardiovascular mortality, deep neural networks yielded the highest clinical performance. The novel mortality prediction models using OBP and ABP outperformed other risk scores. The area under the curve achieved by the novel approach, already when using OBP variables, was significantly higher when compared with the area under the curve of the Framingham risk score, Systemic Coronary Risk Estimation 2, and Atherosclerotic Cardiovascular Disease score. However, the prediction of cardiovascular mortality with ABP instead of OBP data significantly increased the area under the curve (0.870 versus 0.865;
CONCLUSIONS UNASSIGNED
The receiver operating characteristic curves for cardiovascular mortality using ABP and OBP with deep neural network models outperformed all other risk metrics, indicating the potential for improving current risk scores by applying state-of-the-art machine learning approaches. The prediction of cardiovascular mortality using ABP data led to a significant increase in area under the curve and performance metrics.

Identifiants

pubmed: 38660828
doi: 10.1161/HYPERTENSIONAHA.123.22529
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Pedro Guimarães (P)

Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany (P.G., A.K., T.F.).
University of Coimbra, Coimbra Institute for Biomedical Imaging and Translational Research, Institute for Nuclear Sciences Applied to Health, Portugal (P.G.).

Andreas Keller (A)

Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany (P.G., A.K., T.F.).
Department of Neurology and Neurological Sciences, Stanford University, CA (A.K.).

Michael Böhm (M)

Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany (M.B., L.L., F.M.).

Lucas Lauder (L)

Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany (M.B., L.L., F.M.).

Tobias Fehlmann (T)

Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany (P.G., A.K., T.F.).

Luis M Ruilope (LM)

Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. (L.M.R., J.S., G.R.-H.).
CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain. (L.M.R., G.R.-H.).
Faculty of Sport Sciences, European University of Madrid, Spain (L.M.R.).

Ernest Vinyoles (E)

La Mina Primary Care Center, University of Barcelona, Spain (E.V.).
IDIAP Jordi Gol, Barcelona, Spain (E.V.).

Manuel Gorostidi (M)

Department of Nephrology, Hospital Universitario Central de Asturias, REDinREN, Oviedo, Spain (M.G.).

Julián Segura (J)

Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. (L.M.R., J.S., G.R.-H.).

Gema Ruiz-Hurtado (G)

Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. (L.M.R., J.S., G.R.-H.).
CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain. (L.M.R., G.R.-H.).

Natalie Staplin (N)

Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, United Kingdom (N.S.).

Bryan Williams (B)

University College London (UCL), Institute of Cardiovascular Science, National Institute for Health Research, UCL Hospitals Biomedical Research Centre, United Kingdom (B.W.).

Alejandro de la Sierra (A)

Department of Internal Medicine, Hospital Universitario Mútua Terrasa, Universidad de Barcelona, Spain (A.d.l.S.).

Felix Mahfoud (F)

Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany (M.B., L.L., F.M.).
Institute for Medical Engineering and Science, MIT, Cambridge, MA (F.M.).

Classifications MeSH